financetom
Market
financetom
/
Market
/
Wall St Week Ahead-'Crowded' megacap trade in US stocks awaits earnings test
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Wall St Week Ahead-'Crowded' megacap trade in US stocks awaits earnings test
Apr 21, 2024 3:23 AM

NEW YORK, April 19 (Reuters) - Next week's earnings

reports from some of the market's biggest technology and growth

companies could prove an important test for the U.S. stock

rally, which has flagged as expectations for interest cuts fade.

Tesla, Meta Platforms ( META ), Alphabet

and Microsoft ( MSFT ) - all set to report next week - are part

of the group of companies that had been dubbed the Magnificent

Seven as they led the S&P 500 to a 24% gain last year.

The companies are seen as important bellwethers due to

dominant positions atop their industries, while heavy index

weightings give their share price moves an outsize influence on

benchmarks such as the S&P 500. Though the market's rally has

broadened this year, megacap stocks remain a portfolio staple,

with fund managers in the latest BofA Global Research survey

once again naming them the market's "most crowded" trade.

Many believe their results could be especially important to

markets this time around. The S&P 500 has slid in recent weeks,

roughly halving its year-to-date gain to 5% as

stickier-than-expected inflation erodes the prospects for the

Federal Reserve to cut rates this year.

Additionally, the monthslong rally in stocks has made the

index expensive relative to history at a time when rising

Treasury yields are pressuring equity valuations. Disappointing

earnings from the market's heavyweights could give investors

less reason to hold stocks.

"Psychologically, the companies coming in at or above

expectations is important," said David Katz, chief investment

officer with Matrix Asset Advisors. "There's a lot of good news

built into a lot of these companies."

Investors will also focus on next Friday's release of the

monthly Personal Consumption Expenditures Price index, a crucial

piece of inflation data before the Fed's April 30-May 1 meeting.

Fed funds futures late Thursday were pricing in less than 40

basis points in rate cuts this year, down from 150 bps expected

at the start of 2024, according to LSEG data.

The performance of megacaps' shares has diverged in 2024,

after last year's epic run. Tesla, which reports results on

Tuesday, has seen its shares tumble about 40% in 2024 amid

concerns about its electric vehicle business.

Meta Platforms ( META ), whose shares have jumped over 40% in 2024,

is due on Wednesday, while Alphabet and Microsoft ( MSFT ), which are

logging year-to-date gains of about 12% and 7.5% respectively,

are set for Thursday.

Of the other megacaps, Apple ( AAPL ) and Amazon ( AMZN )

are set to report the following week, while Nvidia ( NVDA ),

whose shares have soared 70% this year on optimism over its

artificial intelligence chips, reports on May 22.

Six of the seven, excluding Tesla, are expected to post

collective earnings growth of 42.1% in the first quarter, UBS

strategists said on April 8.

"It appears that the expectations are that they're really

going to deliver again," said Patrick Kaser, portfolio manager

at Brandywine Global. "And so the risk to me is skewed to the

downside."

Excluding the Magnificent 7, S&P 500 earnings have been

negative on a year-over-year basis over the prior four quarters,

according to JPMorgan analysts, underlining the group's

importance to the market.

Beyond the megacaps, over 300 S&P 500 companies expected to

report over the coming two weeks. Earnings are expected to rise

9% for the full year, according to LSEG data, with added

pressure on the results to support overall valuations.

The S&P 500's forward price-to-earnings ratio has moderated

somewhat this month but is still at 20 times, well above its

long-term average of 15.7, according to LSEG Datastream.

"In an environment where there is a lot of uncertainty about

Fed rate policy, there's a lot of geopolitical tensions rising,

if companies aren't really pushing the pedal on giving positive

outlooks for growth ... that could be the factor that weighs on

stocks," said Anthony Saglimbene, chief market strategist at

Ameriprise Financial.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tradeweb Markets Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
Tradeweb Markets Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
Aug 15, 2024
Across the recent three months, 7 analysts have shared their insights on Tradeweb Markets ( TW ) , expressing a variety of opinions spanning from bullish to bearish. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent...
Equities, Yields Rally as Markets Parse Macro Data, Corporate Earnings
Equities, Yields Rally as Markets Parse Macro Data, Corporate Earnings
Aug 15, 2024
04:59 PM EDT, 08/15/2024 (MT Newswires) -- US benchmark equity indexes and Treasury yields surged Thursday, as markets assessed the latest batch of economic data and corporate earnings. The Nasdaq Composite jumped 2.3% to 17,594.5, while the S&P 500 increased 1.6% to 5,543.2. The Dow Jones Industrial Average advanced 1.4% to 40,563.1. Consumer discretionary and technology led sector gainers, while...
Sector Update: Health Care
Sector Update: Health Care
Aug 15, 2024
03:39 PM EDT, 08/15/2024 (MT Newswires) -- Health care stocks rose late Thursday afternoon, with the NYSE Health Care Index increasing 0.5% and the Health Care Select Sector SPDR Fund (XLV) adding 0.6%. The iShares Biotechnology ETF (IBB) gained 1.5%. In sector news, Cingulate ( CING ) shares skyrocketed nearly 170% after it said Thursday it received a European patent...
Home Sales in 51 US Metro Areas Rose 3.8% in July From June, RE/MAX Says; Prices Fell 1.2%
Home Sales in 51 US Metro Areas Rose 3.8% in July From June, RE/MAX Says; Prices Fell 1.2%
Aug 15, 2024
04:48 PM EDT, 08/15/2024 (MT Newswires) -- RE/MAX Holdings ( RMAX ) unit RE/MAX ( RMAX ) said home sales in July rose 3.8% from June while the median price dropped 1.2%, the first decline this year, a survey of 51 US metro areas showed. July home sales rose 6.7% from a year earlier, and the median price increased 3.7%....
Copyright 2023-2026 - www.financetom.com All Rights Reserved